Currently Enrolling Outpatient
BCG vaccine is traditionally used to prevent TB infections and is a routine vaccine for children in epidemic countries. It is not a routine vaccination in the US, considering the low prevalence of TB.
The purpose of this study is to determine how the BCG vaccine affects the immune system and whether it can provide some degree of protection against a variety of infections. The study is:
- 6 months long
- enrolling people 18-65 years old
- includes 1-2 screening visits, 1 vaccination visit, 2 follow up phone calls and 3 follow up visits
- pays up to $440 for completion of all study procedures
Complete the Pre-Screening Survey to see if you qualify for an in-person screening visit
Complete the CIR Contact Form to be contacted by a CIR staff member
Call us for upcoming screening dates!
CIR at Johns Hopkins Bayview Medical Campus
301 Building 4th Floor
301 Mason Lord Drive
Baltimore, MD 21224
$440 for full study compliance